Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease
Open Access
- 1 April 2003
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (4), 423-426
- https://doi.org/10.1136/jnnp.74.4.423
Abstract
Objectives: To elucidate the factors associated with severity of cardiac sympathetic nerve involvement in idiopathic Parkinson’s disease (PD). Methods:123I-metaiodobenzylguanidine uptake was examined in 88 patients with PD. The ratio of the uptake in the heart (H) to that in the mediastinum (M) (the H/M ratio) was calculated and correlated with age at onset, age at examination, and disease severity and duration. Twenty five healthy people were also examined as a control. Results: There was a mild but significant negative correlation between H/M ratio and age at onset (early, r = −0.33, p = 0.002; delayed, r = −0.34, p = 0.001) and between Hoehn and Yahr (H-Y) stage (early, r = −0.30, p = 0.006; delayed, r = −0.32, p = 0.003). There was no significant correlation between disease duration and H/M ratio. When patients with PD were classified into four subgroups on the basis of age at onset (> 62 or < 62 years) and disease severity (H-Y > III or H-Y ⩽ II), the median H/M ratio of the older and more severe group was significantly lower than that of the younger and less severe group (p = 0.005). Conclusion: This study suggests that late onset, high severity PD is associated with myocardial sympathetic dysfunction.This publication has 31 references indexed in Scilit:
- Combined effect of age and severity on the risk of dementia in Parkinson's diseaseAnnals of Neurology, 2002
- Cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Author Index Vol. 57, 2001Brain, Behavior and Evolution, 2001
- Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG–SPECTJournal of the Neurological Sciences, 2000
- Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinsonʼs diseaseNuclear Medicine Communications, 1998
- Autonomic Dysfunction in Parkinson's DiseaseEuropean Neurology, 1997
- A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failureJournal of the Autonomic Nervous System, 1995
- A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failureJournal of the Autonomic Nervous System, 1994
- Does ageing aggravate parkinsonian disability?Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidineJournal of the American College of Cardiology, 1989